Development and evaluation of a cancer-related fatigue patient education program: protocol of a randomized controlled trial

Nina Stuhldreher, Karl Reif, Ulrike de Vries, Stefan Görres, Franz Petermann, Nina Stuhldreher, Karl Reif, Ulrike de Vries, Stefan Görres, Franz Petermann

Abstract

Background: Cancer-related fatigue (CRF) and its impact on patients' quality of life has been an increasing subject of research. However, in Germany there is a lack of evidence-based interventions consistent with the multidimensional character of fatigue. The objective of this study is to develop and evaluate a self-management program for disease-free cancer patients to cope with CRF.

Methods: Based on evidence extracted from a literature review, a curriculum for the self-management program was elaborated. The curriculum was reviewed and validated by an interdisciplinary expert group and the training-modules will be pretested with a small number of participants and discussed in terms of feasibility and acceptance.To determine the efficacy of the program a randomised controlled trial will be carried out: 300 patients will be recruited from oncological practices in Bremen, Germany, and will be allocated to intervention or control group. The intervention group participates in the program, whereas the control group receives standard care and the opportunity to take part in the program after the end of the follow-up (waiting control group). Primary outcome measure is the level of fatigue, secondary outcome measures are quality of life, depression, anxiety, self-efficacy and physical activity. Data will be collected before randomisation, after intervention, and after a follow-up of 6 months.

Discussion: Because there are no comparable self-management programs for cancer survivors with fatigue, the development of the curriculum has been complex; therefore, the critical appraisal by the experts was an important step to validate the program and their contributions have been integrated into the curriculum. The experts appreciated the program as filling a gap in outpatient cancer care.If the results of the evaluation prove to be satisfactory, the outpatient care of cancer patients can be broadened and supplemented.

Trial registration: ClinicalTrials NCT00552552.

Figures

Figure 1
Figure 1
Summary of trial design.

References

    1. National Comprehensive Cancer Network (NCCN) Cancer-Related Fatigue, Clinical Practice Guidelines in Oncology, Version 1 Jenkintown. 2007.
    1. Glaus A, Crow R, Hammond S. Müdigkeit/Fatigue bei Gesunden und bei krebskranken Menschen. Eine qualitative Analyse Teil I. Pflege. 1999;12:11–19. doi: 10.1024/1012-5302.12.1.11.
    1. Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patient during and after treatment: prevalence, correlates and interventions. European Journal of Cancer. 2002;38:27–43. doi: 10.1016/S0959-8049(01)00332-X.
    1. Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. Journal of Clinical Oncology. 2000;18:743–753.
    1. Cella D, Davis K, Breitbart , Curt G. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. Journal of Clinical Oncology. 2001;19:3385–3391.
    1. Loge JH, Abrahamsen AF, Ekeberg O, Kaasa S. Hodgkin's disease survivors more fatigued than general population. Journal of Clinical Oncology. 1999;17:253–261.
    1. Okuyama T, Akechi T, Kugaya A, Okamura H, Imoto S, Nakano T, Mikami I, Hosaka T, Uchitomi Y. Factors correlated with fatigue in disease free breast cancer patients: application of the Cancer Fatigue Scale. Supportive Care in Cancer. 2000;8:215–222. doi: 10.1007/s005200050288.
    1. Stone P, Richardson A, Ream E. Cancer-related fatigue: Inevitable, unimportant and untreatable? Results of a multicentre patient survey. Annals of Oncology. 2000;11:971–975. doi: 10.1023/A:1008318932641.
    1. Curt GA. The impact of fatigue on patients with cancer: Overview of FATIGUE 1 and 2. Oncologist. 2000:9–12. doi: 10.1634/theoncologist.5-suppl_2-9.
    1. Patarca-Montero . Handbook of Cancer-Related Fatigue. New York: Haworth Medical Press; 2004.
    1. Vogelzang N, Breitbart W, Cella D. The Fatigue Coalition. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tri-part assessment survey. Seminars in Haematology. 1997;34:4–12.
    1. Hinds PS, Quargnenti A, Bush AJ. An evaluation of the impact of a self-care coping intervention on psychological and clinical outcomes in adolescents with newly diagnosed cancer. European Journal of Oncological Nursing. 2000;4:6–17. doi: 10.1054/ejon.1999.0051.
    1. Bartsch HH, Weis J, Moser MT. Cancer-Related Fatigue in Patients Attending Oncological rehabilitation Programs: Prevalence, Patterns and Predictors. Onkologie. 2003;26:51–57. doi: 10.1159/000069864.
    1. Steingräber M, Feyer P. Tumorbedingte Fatigue. Onkologie. 2005;37:52–57.
    1. Portenoy RK, Itri LM. Cancer-Related Fatigue: Guidelines for Evaluation and Management. The Oncologist. 1999;4:1–10.
    1. Visser MR, Smets EM. Fatigue, depression and quality of life in cancer patients: how are they related? Supportive Care in Cancer. 1998;6:101–8. doi: 10.1007/s005200050142.
    1. Servaes P, Werf S van der, Prins J, Verhagen S, Bleijenberg G. Fatigue in disease-free cancer patients compared with fatigue in patients with Chronic Fatigue Syndrome. Supportive Care in Cancer. 2000;9:11–17. doi: 10.1007/s005200000165.
    1. Young K, White C. The prevalence and moderators of fatigue in people who have been successfully treated for cancer. Journal of Psychosomatic Research. 2006;60:29–38. doi: 10.1016/j.jpsychores.2005.03.011.
    1. Groopman JE, Itri L. Chemotherapy induced anaemia in adults: Incidence and treatment. Journal of the National Cancer Institute. 1999;91:1616–1634. doi: 10.1093/jnci/91.19.1616.
    1. Gabrilove JL, Cleeland CS, Livingston RB. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in haemoglobin and quality of life are similar to three-times-weekly dosing. Journal of Clinical Oncology. 2001;19:2875–2882.
    1. Crevenna R, Zielinski CH, Keilani M. Aerobes Ausdauertraining für Krebspatienten. Wiener Medizinische Wochenschrift. 2003;153:212–216. doi: 10.1046/j.1563-258X.2003.02080.x.
    1. Mock V, Pickett M, Ropka F. Fatigue and quality of life outcomes of exercise during cancer treatment. Cancer Practice. 2001;9:119–127. doi: 10.1046/j.1523-5394.2001.009003119.x.
    1. Courneya KS, Mackey JR, Bell GL. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. Journal of Clinical Oncology. 2003;21:1660–1668. doi: 10.1200/JCO.2003.04.093.
    1. Coleman EA, Coon S, Hall-Barrow J. Feasibility of exercise during treatment for multiple myeloma. Cancer Nursing. 2003;26:410–419. doi: 10.1097/00002820-200310000-00012.
    1. Berger AM, Farr L. The Influence of daytime inactivity and night time restlessness on cancer-related fatigue. Oncol Nurs Forum. 1999;26:1663–1671.
    1. Ream E, Browne N, Glaus A. Quality and efficacy of education materials on cancer-related fatigue: views of patients from two European countries. European Journal of Oncological Nursing. 2003;7:99–109. doi: 10.1016/S1462-3889(03)00003-6.
    1. Glaus A, Frei IA, Knipping C, Ream E, Browne N. Was Krebskranke von den Informationen über Fatigue halten: eine Beurteilung durch Patienten in der Schweiz und in England. Pflege. 2002;15:187–194. doi: 10.1024/1012-5302.15.5.187.
    1. Ahlberg K, Ekman T, Gaston-Johansson F, Mock V. Assessment and management of cancer-related fatigue in adults. The Lancet. 2003;362:640–650. doi: 10.1016/S0140-6736(03)14186-4.
    1. Hewitt J, Mokbel K, van Someren K. Exercise for breast cancer survival: the effect on cancer risk and cancer-related fatigue (crf) Int J Fertil Womens Med. 2005;50:321–329.
    1. Jacobsen PB, Mead CD, Stein KD, et al. Efficacy and costs of two forms of stress management training for cancer patients undergoing chemotherapy. Journal of Clinical Oncology. 2002;20:2851–2862. doi: 10.1200/JCO.2002.08.301.
    1. Gaston-Johansson F, Fall-Dickson JM, Nanda J, et al. The effectiveness of the comprehensive coping strategy program on clinical outcomes in breast cancer autologous bone marrow transplantation. Cancer Nursing. 2000;23:277–285. doi: 10.1097/00002820-200008000-00004.
    1. Oken MM, Creech RH, Tormey DC, Horton J, et al. Toxicity and Response Criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology. 1982;5:649–655. doi: 10.1097/00000421-198212000-00014.
    1. Glaus A, Müller S. Messung der Müdigkeit bei Krebskranken im Deutschen Sprachraum: Die Entwicklung des Fatigue Assessment Questionnaires. Pflege. 2001;14:161–170. doi: 10.1024/1012-5302.14.3.161.
    1. Jerusalem M, Schwarzer R. In: Selbstwirksamkeit WIRK (Hrsg): Skalen zur Befindlichkeit und Persönlichkeit Forschungsbericht 5. Schwarzer R, editor. Berlin: Freie Universität, Institut für Psychologie; 1986. pp. 15–18.
    1. Fuchs R, Schwarzer R. Selbstwirksamkeit zur sportlichen Aktivität: Reliabilität und Validität eines neuen Meßinstruments. Zeitschrift für Differentielle und Diagnostische Psychologie. 1994;14:141–154.
    1. Frey I, Berg A, Grathwohl D, Keul J. Freiburger Fragebogen zur körperlichen Aktivität – Entwicklung, Prüfung und Anwendung. Sozial- und Präventivmedizin. 1999;44:55–64. doi: 10.1007/BF01667127.
    1. Herrmann C, Buss U, Snaith RP. Manual. Bern: Hans Huber; 1995. Hospital Anxiety and Depression Scale – Deutsche Version (HADS-D)
    1. Hjermstad MJ, Fossa SD, Bjorda K, Kaasa S. Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. Journal of Clinical Oncology. 1995;13:1249–1254.
    1. Schön D, Bertz J, Görsch B, et al. Entwicklung der Überlebensraten von Krebspatienten in Deutschland. Schwerpunktbericht der GBE für Deutschland, Robert Koch-Institut, Berlin; 1999.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe